Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridostigmine for inflammatory CRPS-I
NL-OMON20521Not yet recruiting
- Sponsor
- TREND Community
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of pyridostigmine in Complex Regional Pain Syndrome Type 1 (CRPS-1), sponsored by TREND Community. Primary endpoints: Pain, Motor function and 3 more. Planned start Apr 2009; status: not yet recruiting.
02
Drugs
pyridostigmine
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)
Beyond the preview
Go deeper on NL-OMON20521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20521.